Altucci L - Search Results

1

Indole-derived psammaplin A analogues as epigenetic modulators with multiple inhibitory activities.

Pereira R, Benedetti R, Pérez-Rodríguez S, Nebbioso A, García-Rodríguez J, Carafa V, Stuhldreier M, Conte M, Rodríguez-Barrios F, Stunnenberg HG, Gronemeyer H, Altucci L, de Lera AR. Pereira R, et al. Among authors: altucci l. J Med Chem. 2012 Nov 26;55(22):9467-91. doi: 10.1021/jm300618u. Epub 2012 Oct 17. J Med Chem. 2012. PMID: 23030799

2

Nuclear receptors in cell life and death.

Altucci L, Gronemeyer H. Altucci L, et al. Trends Endocrinol Metab. 2001 Dec;12(10):460-8. doi: 10.1016/s1043-2760(01)00502-1. Trends Endocrinol Metab. 2001. PMID: 11701345 Review.

3

The promise of retinoids to fight against cancer.

Altucci L, Gronemeyer H. Altucci L, et al. Nat Rev Cancer. 2001 Dec;1(3):181-93. doi: 10.1038/35106036. Nat Rev Cancer. 2001. PMID: 11902573 Review.

4

Decryption of the retinoid death code in leukemia.

Altucci L, Gronemeyer H. Altucci L, et al. J Clin Immunol. 2002 May;22(3):117-23. doi: 10.1023/a:1015490627613. J Clin Immunol. 2002. PMID: 12078852 Review.

5

Leukemia: beneficial actions of retinoids and rexinoids.

Altucci L, Wilhelm E, Gronemeyer H. Altucci L, et al. Int J Biochem Cell Biol. 2004 Feb;36(2):178-82. doi: 10.1016/s1357-2725(03)00247-4. Int J Biochem Cell Biol. 2004. PMID: 14643883 Review.

6

Retinoids and TRAIL: two cooperating actors to fight against cancer.

Altucci L, Gronemeyer H. Altucci L, et al. Vitam Horm. 2004;67:319-45. doi: 10.1016/S0083-6729(04)67017-8. Vitam Horm. 2004. PMID: 15110184 Review.

7

Retinoids: potential in cancer prevention and therapy.

Clarke N, Germain P, Altucci L, Gronemeyer H. Clarke N, et al. Among authors: altucci l. Expert Rev Mol Med. 2004 Nov 30;6(25):1-23. doi: 10.1017/S1462399404008488. Expert Rev Mol Med. 2004. PMID: 15569396 Review.

8

Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells.

Nebbioso A, Clarke N, Voltz E, Germain E, Ambrosino C, Bontempo P, Alvarez R, Schiavone EM, Ferrara F, Bresciani F, Weisz A, de Lera AR, Gronemeyer H, Altucci L. Nebbioso A, et al. Among authors: altucci l. Nat Med. 2005 Jan;11(1):77-84. doi: 10.1038/nm1161. Epub 2004 Dec 26. Nat Med. 2005. PMID: 15619633 Free article.

9

Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides.

Mai A, Massa S, Pezzi R, Simeoni S, Rotili D, Nebbioso A, Scognamiglio A, Altucci L, Loidl P, Brosch G. Mai A, et al. Among authors: altucci l. J Med Chem. 2005 May 5;48(9):3344-53. doi: 10.1021/jm049002a. J Med Chem. 2005. PMID: 15857140

10

Acute myeloid leukemia: therapeutic impact of epigenetic drugs.

Altucci L, Clarke N, Nebbioso A, Scognamiglio A, Gronemeyer H. Altucci L, et al. Int J Biochem Cell Biol. 2005 Sep;37(9):1752-62. doi: 10.1016/j.biocel.2005.04.019. Int J Biochem Cell Biol. 2005. PMID: 15964234 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters